Moberg Pharma
34,2 SEK -0,87%2 investorer følger denne virksomhed
Moberg Pharma is a Swedish pharmaceutical company focused on the commercialization of proprietary medicines based on proven substances. The company mainly works in nail fungus, where Moberg Pharma is developing a new external treatment. The company has agreements with commercial partners on site in Europe and Asia, among other places. The head office is in Bromma.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
MOB
Daglig lav / høj pris
32,22 / 35,44
SEK
Markedsværdi
971,53 mio. SEK
Aktieomsætning
7,78 mio. SEK
Volumen
231 t
Seneste videoer
Finanskalender
Delårsrapport
07.05.2024
Generalforsamling
14.05.2024
Delårsrapport
13.08.2024
Delårsrapport
12.11.2024
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Östersjöstiftelsen | 11,5 % | 11,5 % |
Avanza Pension | 6,4 % | 6,4 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Moberg Pharma Annual report for 2023
Moberg Pharma: The Nomination Committee's proposal to the Annual General Meeting 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools